TSPAN5 and hepatocellular carcinoma: As discussed in the previous section, there is recent evidence that Tspan5 enhances Notch signaling to promote hepatocellular carcinoma [69], and a Tspan5 antibody has Notch inhibitory activity in a cell line model [59].